-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HhlH1K2Ck9JvyaLfddz20eXpXZhF8IhKgWVbG2Q71qY5lT72bFrokezrq0od6xCm czCw//LzdE+7b3coJ+bPlg== 0001209191-06-063269.txt : 20061206 0001209191-06-063269.hdr.sgml : 20061206 20061206163710 ACCESSION NUMBER: 0001209191-06-063269 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061205 FILED AS OF DATE: 20061206 DATE AS OF CHANGE: 20061206 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVEN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000815838 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 592767632 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11960 SW 144TH ST CITY: MIAMI STATE: FL ZIP: 33186 BUSINESS PHONE: 3052535099 MAIL ADDRESS: STREET 1: 11960 SW 144TH STREET CITY: MIAMI STATE: FL ZIP: 33185 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ABRAO EDUARDO G CENTRAL INDEX KEY: 0001259862 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17254 FILM NUMBER: 061260439 MAIL ADDRESS: STREET 1: 11960 SW 144TH STREET STREET 2: NOVEN PHARMACUTICALS INC CITY: MIAMI STATE: FL ZIP: 33186 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2006-12-05 0 0000815838 NOVEN PHARMACEUTICALS INC NOVN 0001259862 ABRAO EDUARDO G C/O NOVEN PHARMACEUTICALS, INC. 11960 S.W. 144TH STREET MIAMI FL 33186 0 1 0 0 VP & Chief Medical Officer Common Stock ($ .0001 par value) 2006-12-05 4 M 0 7715 13.68 A 7715 D Common Stock ($ .0001 par value) 2006-12-05 4 S 0 7715 25.00 D 0 D Stock Option (Right to Buy) 13.68 2006-12-05 4 M 0 7715 0.00 D 2012-11-14 Common Stock ($.0001 par value) 7715 23149 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2006. 25% exercisable beginning on 11/15/2006; 25% exercisable beginning on 11/15/07; 25% exercisable beginning on 11/15/2008; and 25% exercisable beginning on 11/15/09. /s/ Eduardo G. Abrao 2006-12-06 -----END PRIVACY-ENHANCED MESSAGE-----